EEPD1 Deficiency Drives Diabetic Kidney Disease Progression via Amplified Genotoxic Stress and Downregulation of EHHADH

Clicks: 16
ID: 339475
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #66 of 66 articles by views in journal of molecular cell biology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Diabetic kidney disease (DKD), a major microvascular complication of diabetes, is characterized by oxidative stress and chronic inflammation that collectively promote cellular DNA damage and tubular injury. Although these pathological mechanisms are well recognized, the contribution of DNA repair enzymes to DKD progression remains largely unexplored. Here, we identify endonuclease/exonuclease/phosphatase family domain-containing 1 (EEPD1), a key DNA damage response enzyme, as a novel renoprotective factor in DKD. We found that EEPD1 protein abundance was significantly reduced in the kidneys of high-fat diet/streptozotocin (HFD/STZ)-induced diabetic mice and db/db mice (two widely used murine models of DKD) and in human proximal tubular epithelial cells (HK-2) exposed to high glucose. Genetic ablation of Eepd1 in mice exacerbated renal injury, fibrosis, and dysfunction in both HFD/STZ-induced and HFD-induced diabetic models. Transcriptomic and biochemical analyses revealed that Eepd1 deficiency promoted DNA damage accumulation, inflammatory activation, and metabolic dysregulation, particularly through suppression of the peroxisomal fatty acid oxidation (FAO) enzyme EHHADH, at both mRNA and protein levels. Integrated transcriptional analyses and functional validation further identified PPARα as a critical transcriptional mediator linking EEPD1 to EHHADH regulation. Mechanistically, EEPD1 deficiency reduced PPARα expression, whereas PPARα depletion impaired EEPD1-dependent activation of EHHADH expression and promoter activity. Collectively, our findings identify an EEPD1–PPARα–EHHADH regulatory axis that connects DNA repair with peroxisomal metabolic homeostasis and establishes EEPD1 as a potential therapeutic target for DKD.
Reference Key
openalex_W7225745258 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Qian Zhou, Qiqi Qian, 殷立敏, Quanxin Jiang, Ying Xu, Anran Liu, Liaoyuan Zheng, Hanrui Yin, Liu Han, Lulu Sheng, Yongxia Li, Peihui Zhou, Suzhen Chen
Are you one of these authors? Claim your profile
Journal journal of molecular cell biology
Year 2026
DOI
10.1093/jmcb/mjag048
URL
https://doi.org/10.1093/jmcb/mjag048
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.